Immunologic consequences of multiple, high-dose administration of allogeneic mesenchymal stem cells to baboons

Cell Transplantation

Volumn 15, Issue 8-9, 2006, Pages 711-721

  Beggs, Kirstin J ^a   Lyubimov, Alex ^b   Borneman, Jade N ^a   Bartholomew, Amelia ^b   Moseley, Annemarie ^a   Dodds, Robert ^a   Archambault, Michael P ^a   Smith, Alan K ^a   McIntosh, Kevin R ^a,c  

^a OSIRIS THERAPEUTICS INC   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c Cognate BioServices Inc ^*  (United States)

Author keywords

Alloantibody; Allogeneic; Baboons; Immunogenicity; Mesenchymal stem cells; T cell hyporesponsiveness

Indexed keywords

ALLOANTIBODY; ALLOANTIGEN; CONCANAVALIN A; IMMUNOGLOBULIN; MITOGENIC AGENT;

ALLOGENEIC STEM CELL TRANSPLANTATION; ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; BABOON; CELL SURVIVAL; CONTROLLED STUDY; EVALUATION; FEMALE; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOMODULATION; MESENCHYMAL STEM CELL; MUSCLE BIOPSY; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; SAFETY; T LYMPHOCYTE;

ANIMALIA; PAPIO;

EID: 33846229305     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/000000006783981503     Document Type: Article

References (33)

1. Aggarwal, S.; Pittenger, M. F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105:1815-1822; 2005.
2. Bartholomew, A.; Sturgeon, C.; Siatskas, M.; Ferrer, K.; McIntosh, K. R.; Patil, S.; Hardy, W.; Devine, S.; Ucker, D.; Deans, R.; Moseley, A.; Hoffman, R. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp. Hematol. 30:42-48; 2002.
3. Bradley, J. A.; Bolton, E. M.; Pedersen, R. A. Stem cell medicine encounters the immune system. Nat. Rev. Immunol. 2:859-871; 2002.
4. Camirand, G.; Caron, N.; Asselin, I.; Tremblay, J. P. Combined immunosuppression of mycophenolate mofetil and FK506 for myoblast transplantation in mdx mice. Transplantation 72:38-44; 2001.
5. Caplan, F. Mesenchymal stem cells. J. Orthop. Res. 9:641-650; 1991.
6. Carpenter, C. B.; d'Apice, A. J. F.; Abbas, A. K. The role of antibodies in the rejection and enhancement of organ allografts. Adv. Immunol. 22:1-65; 1976.
7. Deans, R. J.; Moseley, A. B. Mesenchymal stem cells: Biology and potential clinical uses. Exp. Hematol. 28:875-884; 2000.
8. Deng, W.; Han, Q.; Liao, L.; Li, C.; Ge, W.; Zhao, Z.; You, S.; Deng, H.; Zhao, C. H. Allogeneic bone marrow-derived flk-1+Sca-1- mesenchymal stem cells leads to stable mixed chimerism and donor-specific tolerance. Exp. Hematol. 32:861-867; 2004.
9. Devine, S. M.; Peter, S.; Martin, B. J.; Barry, F.; McIntosh, K. R. Mesenchymal stem cells: Stealth and suppression. Cancer J. 7:S76-82; 2001.
10. Devine, S. M.; Cobbs, C.; Jennings, M.; Bartholomew, A.; Hoffman, R. Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into non-human primates. Blood 101:2999-3001; 2003.
11. Di Nicola, M.; Carlo-Stella, C.; Magni, M.; Milanesi, M.; Longoni, P. D.; Matteucci, P.; Grisanti, S.; Gianni, A. M. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99:3838-3843; 2002.
12. Djouad, F.; Plence, P.; Bony, C.; Tropel, P.; Apparailly, F.; Sany, J.; Noël, D.; Jorgensen, C. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 102:3837-3844; 2003.
13. Friedenstein, A. J. Precursor cells of mechanocytes. Int. Rev. Cytol. 47:327-359; 1976.
14. Glennie, S.; Soeiro, I.; Dyson, P. J.; Lam, E. W.; Dazzi, F. Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood 105:2821-2827; 2005.
15. Haynesworth, S. E.; Baber, M. A.; Caplan, A. I. Cell surface antigens on human bone marrow-derived mesenchymal stem cells are detected by monoclonal antibodies. Bone 13:69-80; 1992.
16. Huston, D. P. The biology of the immune system. JAMA 278:1804-1814; 1997.
17. Kawai, T.; Poncelet, A.; Sachs, D. H.; Mauiyyedi, S.; Boskovic, S.; Wee, S. L.; Ko, D. S.; Bartholomew, A.; Kimikawa, M.; Hong, H. Z.; Abrahamian, G.; Colvin, R. B.; Cosimi, A. B. Long-term outcome and alloantibody production in a non-myeloablative regimen for induction of renal allograft tolerance. Transplantation 68:1767-1775; 1999.
18. Klyushnenkova, E.; Mosca, J. D.; Zernetkina, V.; Majumdar, M. K.; Beggs, K. J.; Simonetti, D. W.; Deans, R. J.; McIntosh, K. R. T cell responses to allogeneic human mesenchymal stem cells: Immunogenicity, tolerance, and suppression. J. Biomed. Sci. 12:47-57; 2005.
19. Lazarus, H. M.; Koc, O. N. Culture-expanded human marrow-derived MSCs in clinical hematopoietic stem cell transplantation. Graft 3:329-333; 2000.
20. Le Blanc, K.; Tammik, L.; Sundberg, B.; Haynesworth, S. E.; Ringden, O. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand. J. Immunol. 57:11-20; 2003.
21. Le Blanc, K.; Rasmusson, I.; Sundberg, B.; Götherström, C.; Hassan, M.; Uzunel, M.; Ringdén, O. Treatment of severe acute graft- versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363:1439-1441; 2004.
22. Li, Y.; McIntosh, K.; Chen, J.; Zhang, C.; Gao, Q.; Borneman, J.; Raginski, K.; Mitchell, J.; Shen, L.; Zhang, J.; Lu, D.; Chopp, M. Allogeneic bone marrow stromal cells promote glial-axonal remodeling without immunologic sensitization after stroke in rats. Exp. Neurol. 198:313-325; 2006.
23. Liechty, K. W.; MacKenzie, T. C.; Shaaban, A. F.; Radu, A.; Moseley, A. M.; Deans, R.; Marshak, D. R.; Flake, A. W. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat. Med. 6:1282-1286; 2000.
24. Majumdar, M. K.; Keane-Moore, M.; Buyaner, D.; Hardy, W. B.; Moorman, M. A.; McIntosh, K. R.; Mosca, J. D. Characterization and functionality of cell surface molecules on human mesenchymal stem cells. J. Biomed. Sci. 10:228-241; 2003.
25. Malejczyk, J.; Osiecka, A.; Hyc, A.; Moskalewski, S. Effect of immunosuppression on rejection of cartilage formed by transplanted allogeneic rib chondrocytes in mice. Clin. Orthop. 269:266-273; 1991.
26. Mason, D. W.; Morris, P. J. Effector mechanisms in allograft rejection. Annu. Rev. Immunol. 4:119-145; 1986.
27. McIntosh, K.; Bartholomew, A. Stromal cell modulation of the immune system. A potential role for mesenchymal stem cells. Graft 3:324-328; 2000.
28. Meisel, R.; Zibert, A.; Laryea, M.; Göbel, U.; Däubener, W.; Dilloo, D. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood 103:4619-4621; 2004.
29. Owen, M. E. Marrow stromal cells. J. Cell Sci. 10:63-76; 1988.
30. Pittenger, M. F.; Mackay, A. M.; Beck, S. C.; Jaiswal, R. K.; Douglas, R.; Mosca, J. D.; Moorman, M. A.; Simonetti, D. W.; Craig, S.; Marshak, D. R. Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147; 1999.
31. Saito, T.; Kuang, J-Q.; Bittira, B.; Al-Khaldi, A.; Chiu, R. C-J. Xenotransplant cardiac chimera: immune tolerance of adult stem cells. Ann. Thorac. Surg. 74:19-24; 2002.
32. Tse, W. T.; Pendleton, J. D.; Bever, W. M.; Egalka, M. C.; Guinan, E. C. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: Implications in transplantation. Transplantation 75:389-397; 2003.
33. Zappia, E.; Casazza, S.; Pedemonte, E.; Benvenuto, F.; Bonanni, I.; Gerdoni, E.; Giunti, D.; Ceravolo, A.; Cazzanti, F.; Frassoni, F.; Mancardi, G.; Uccelli, A. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T cell anergy. Blood 106:1755-1761; 2005.